Flexeril and Isentress drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Flexeril (cyclobenzaprine hydrochloride) and Isentress (raltegravir potassium). Common drug interactions include hand fracture among females and pain among males.
The phase IV clinical study analyzes what interactions people have when they take Flexeril and Isentress. It is created by eHealthMe based on reports of 42 people who take the same drugs from the FDA, and is updated regularly.
What is Flexeril?
Flexeril has active ingredients of cyclobenzaprine hydrochloride. It is often used in muscle spasms. eHealthMe is studying from 38,308 Flexeril users. Check the latest studies of Flexeril.
What is Isentress?
Isentress has active ingredients of raltegravir potassium. It is often used in hiv infection. eHealthMe is studying from 16,529 Isentress users. Check the latest studies of Isentress.
42 people who take Flexeril and Isentress together, and have interactions are studied.

What are the common drug interactions of Flexeril and Isentress, by gender? *:
female:
- Hand fracture
- Joint injury
- Proteinuria (presence of protein in the urine)
- Renal injury (kidney injury)
- Subcutaneous abscess
- Weight decreased
- Pain
- Emotional distress
- Anhedonia (inability to experience pleasure from activities usually found enjoyable)
- Anxiety
male:
- Pain
- Anhedonia (inability to experience pleasure from activities usually found enjoyable)
- Paranoia (psychotic disorder characterized by delusions of persecution with or without grandeur)
- Renal impairment (severely reduced kidney function)
- Quality of life decreased
- Arthralgia (joint pain)
- Fatigue (feeling of tiredness)
- Osteopenia (a condition where bone mineral density is lower than normal)
- Hallucination, auditory (perceiving sounds without auditory stimulus)
- Renal failure (kidney dysfunction)
What are the common drug interactions of Flexeril and Isentress, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
- Anhedonia (inability to experience pleasure from activities usually found enjoyable)
- Anxiety
- Depression
- Emotional distress
- Lethargy (tiredness)
- Pain
- Quality of life decreased
- Renal failure (kidney dysfunction)
- Seizure (abnormal excessive or synchronous neuronal activity in the brain)
30-39:
- Anhedonia (inability to experience pleasure from activities usually found enjoyable)
- Anxiety
- Arthralgia (joint pain)
- Bone density decreased
- Bone loss
- Cervical radiculopathy (disturbance of nerve function that causes pain in the upper body)
- Depression
- Emotional distress
- Fracture
- Hand fracture
40-49:
- Chronic kidney disease
- Pain
- Osteonecrosis (death of bone)
- Anhedonia (inability to experience pleasure from activities usually found enjoyable)
- Anxiety
- Emotional distress
- Renal impairment (severely reduced kidney function)
- Blood creatinine increased
- Bone density decreased
- Decreased activity
50-59:
- Emotional distress
- Pain
- Anhedonia (inability to experience pleasure from activities usually found enjoyable)
- Anxiety
- Osteoporosis (bones weak and more likely to break)
- Bone density decreased
- Chronic kidney disease
- Fatigue (feeling of tiredness)
- Depression
- Decreased activity
60+:
- Chronic kidney disease
- Anhedonia (inability to experience pleasure from activities usually found enjoyable)
- Hand fracture
- Ill-defined disorder
- Immune system disorder
- Joint injury
- Osteoporosis (bones weak and more likely to break)
- Protein urine present
- Renal impairment (severely reduced kidney function)
- Skeletal injury (bone and supporting muscle injury)
What are the existing conditions these people have? *
- Pain: 11 people, 26.19%
- Depression: 8 people, 19.05%
- High Blood Pressure: 8 people, 19.05%
- Asthma: 7 people, 16.67%
- Prostatomegaly (enlargement of the prostate): 6 people, 14.29%
- Bacterial Infection: 6 people, 14.29%
- Stress And Anxiety: 6 people, 14.29%
- Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 6 people, 14.29%
- Chest Pain: 5 people, 11.90%
- Constipation: 5 people, 11.90%
* Approximation only. Some reports may have incomplete information.
Do you take Flexeril and Isentress?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Flexeril and Isentress:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Flexeril:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Isentress:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Flexeril and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Isentress and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on cyclobenzaprine hydrochloride and raltegravir potassium (the active ingredients of Flexeril and Isentress, respectively), and Flexeril and Isentress (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Mirena cause Hepatic Enzyme Increased? - 2 seconds ago
- Could Subutex cause Vaginal Bleeding? - 5 seconds ago
- Age-Related Macular Degeneration and Tremor - 13 seconds ago
- Could Symbicort cause Spinal Pain? - 13 seconds ago
- Drug interactions of Hydrocortisone and Eszopiclone - 40 seconds ago
- Drug interactions of Clopra and Fenoterol Hydrobromide - 43 seconds ago
- Micardis Hct vs. Capoten, side effect and effectiveness comparison - 51 seconds ago
- Could Alginate cause Abdominal Pain? - 52 seconds ago
- Could Lidocaine cause Pleural Effusion? - 57 seconds ago
- Drug interactions of Onglyza and Oxycontin - 59 seconds ago